Tarun Puri

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in <i>RET</i> Fusion–Positive NSCLC

Caicun Zhou, Benjamin Solomon, Herbert H. Loong et al. · New England Journal of Medicine · 2023 · 213 citations · Full text

Medicine, Oncology, Pharmacology +14

Selpercatinib in Patients With <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

Alexander Drilon, Vivek Subbiah, Oliver Gautschi et al. · Journal of Clinical Oncology · 2022 · 205 citations · Full text

Medicine, Oncology, Pharmacology +8

Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

Ying Cheng, Haruyasu Murakami, Pan‐Chyr Yang et al. · Journal of Clinical Oncology · 2016 · 187 citations

Medicine, Oncology, Pharmacotherapy +14

A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival

Prasenjit Das, Tarun Puri, Prerana Jha et al. · Journal of Clinical Neuroscience · 2010 · 74 citations

Medicine, Oncology, Pathology +16

Paraplegia due to extramedullary hematopoiesis in thalassemia treated successfully with radiation therapy

Muhammad Imran Malik, Lakshmi Sadasivan Pillai, Nidhi Gogia et al. · Haematologica · 2007 · 47 citations · Full text

Medicine, Hematology, Surgery +11